Tricida eyeing sale, cost-cutting options after failing high-stakes CKD wager

Tricida is looking at all of its options — not even two weeks after watching its stock nosedive.

In an announcement Wednesday afternoon, Tricida didn’t mince words.

“… the Board of Directors has authorized Tricida to initiate a review of strategic alternatives to maximize stakeholder value. This strategic review may include consideration of the sale of the Company and/or its assets.”